Your browser doesn't support javascript.
loading
Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment.
Kitahara, Hideaki; Maruyama, Dai; Maeshima, Akiko Miyagi; Makita, Shinichi; Miyamoto, Ken-Ichi; Fukuhara, Suguru; Munakata, Wataru; Suzuki, Tatsuya; Kobayashi, Yukio; Tajima, Kinuko; Terauchi, Takashi; Kurihara, Hiroaki; Taniguchi, Hirokazu; Komatsu, Norio; Tobinai, Kensei.
  • Kitahara H; Department of Hematology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Maruyama D; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Maeshima AM; Department of Hematology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. dmaruyam@ncc.go.jp.
  • Makita S; Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan.
  • Miyamoto KI; Department of Hematology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Fukuhara S; Department of Hematology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Munakata W; Department of Hematology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Suzuki T; Department of Hematology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Kobayashi Y; Department of Hematology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Tajima K; Department of Hematology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Terauchi T; Department of Hematology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Kurihara H; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
  • Taniguchi H; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
  • Komatsu N; Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan.
  • Tobinai K; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Ann Hematol ; 96(3): 411-420, 2017 Mar.
Article en En | MEDLINE | ID: mdl-27928587

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article